mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |